Navigation Links
DNASequencing.com and a Portfolio of 318 'Genetic' Domain Names to be Auctioned Off at Epik.com Domain Development Conference
Date:9/14/2010

SEATTLE, Sept. 14 /PRNewswire/ -- Epik.com, a leading domain name development company, will release a list of DNA and Genetic developed domain names to be auctioned off on September 16, at 1:30 pm at the Bell Harbor Conference Center Bay Auditorium in Seattle. The domain auction is part of the inaugural Epik.com Domain Developers Conference being held September 15 – 17.  The live auction event is open to the public.

The auction lot contains the premium domain name and website www.DNASequencing.com, as well as an additional 318 DNA and genetics-related informational domain names. Scientists believe DNA sequencing will revolutionize preventative medicine, as knowing the genetic blueprints of an individual will reveal predispositions for specific conditions and diseases such as cancer, diabetes, addiction, etc and lead to 'personalized medicine'.

"Owning a massive amount of Internet Real Estate associated with DNA Sequencing, genetic mapping and personalized medicine can be a windfall for a biotechnology company that wants to control the space and capture the associated Internet search traffic," says Rob Monster, Chairman and CEO of Epik.com. "Companies like Illumina, Complete Genomics, Pacific Biosystems, IBM, Agilent, Alpha Biolab, Ambrygen, Biobasic, Elimbio, Genewiz, Genscript, Ion Torrent, Mpbio, Laragen, Sequenom, Sequetech, Seqwright, etc. could effectively control the marketplace overnight by owning these domains," said Monster.

The auction lot will feature such domains as DNAsequencing.com, DNAsequence.com, DNAmap.com, DNAcode.com, DNAlaboratory.com, GenomeCode.com, GenomeCodes.com, GeneticDoctor.com, GeneticLab.com, GeneticEngineer.com, GeneticTechnology.com and more.

Interested parties can participate in the live auction in-person or online through a real-time Internet interface. Those wanting to submit a proxy bid for the domain and website auction can contact Epik.com directly for more information and instructions. The auction is managed by Moniker® (www.moniker.com) and SnapNames® (www.snapnames.com), both Oversee.net® companies and providers of domain name registration, management, monetization, and brokerage services. Bidders can follow the auction live and, bid online or in person. Conference details can be found at: http://www.Epik.com/conf.

About Epik.com

Epik.com was founded in 2009 with a simple goal – to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the potential associated with an intuitive domain name. Epik.com is based in Seattle and is a leading provider of managed solutions for domain investing serving the needs of individuals and institutions that seek exposure to the domain name asset class.

http://www.Epik.com

http://www.Twitter.com/EpikDotCom

http://www.Facebook.com/EpikDotCom

http://www.YouTube.com/watch?v=Z2HwPgmcvEM


'/>"/>
SOURCE Epik.com
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
2. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
3. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
6. Mendel Announces US Miscanthus Field Trial Results: Second Year Data Demonstrate High-Yielding, Genetically Diverse Product Portfolio
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
9. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
10. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
11. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature their ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused BiOS ... InGaAs PIN diode standard packages feature a TO-46 metal can with active areas of ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC reports ... program, Sonalink™ remote monitoring. The inaugural launch of this new technology occurred over ... Dr. Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... a research registry built on the secure online PatientCrossroads platform, has exceeded both ... 1,600 participants have joined the PROMPT study, which seeks to advance understanding of ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... is now available on Microsoft Azure. On Azure, Arvados provides capabilities for managing ... saw clear demand for Microsoft Azure from major institutions collecting and analyzing genomic ...
Breaking Biology Technology:
(Date:2/10/2016)... , February 10, 2016 ... According to 2016 iris recognition market report, ... recognition is more widely accepted for border ... both fingerprint and iris recognition technology in ... to avoid purchasing two individual biometrics devices. ...
(Date:2/9/2016)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... fourth quarter and year ended December 31, 2015.  ... of 2015 was $6.9 million, an increase of 61% compared to ... the fourth quarter of 2015 was $2.6 million compared to $0.2 ... --> --> Higher revenue and operating income in ...
(Date:2/9/2016)... , Feb. 9, 2016 Vigilant Solutions announces today ... reader (LPR) to develop a lead in a difficult homicide ... LPR data to locate the suspect vehicle. Due to the ... case have been omitted at the agency,s request. ... agency explains, "Our victim was found deceased at an intersection ...
Breaking Biology News(10 mins):